Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1988 Jun;69(3):403–411.

Inhibition of bile secretion in the rat by serum ultrafiltrates and fractions from patients with fulminant hepatic failure.

Y Fukumoto 1, R D Hughes 1, C D Gove 1, R Williams 1
PMCID: PMC2013100  PMID: 3390389

Abstract

The effects of serum ultrafiltrates and fractions from patients with fulminant hepatic failure (FHF) on bile production in the rat were investigated. When serum ultrafiltrates (mol. wt less than 10,000) were infused into the portal vein bile flow showed a significant decrease with FHF ultrafiltrate (90.4 +/- s.e. 2.0% of baseline at the end of infusion, n = 4) compared with a small increase on infusion of normal ultrafiltrate (107.9 +/- 3.4%, n = 6, P less than 0.025). Bile acid output was significantly decreased by FHF ultrafiltrate (62.0 +/- 2.3%., P less than 0.005). Chromatography of the ultrafiltrates on Sephadex G-25 gave two fractions from FHF serum which produced similar changes as with whole ultrafiltrate on bile secretion. Thus, toxic substances accumulating in the circulation of patients with FHF could reduce bile flow and impair the recovery of hepatic function.

Full text

PDF
403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam A. N., Poston L., Wilkinson S. P., Golindano C. G., Williams R. A study in vitro of the sodium pump in fulminant hepatic failure. Clin Sci Mol Med. 1978 Oct;55(4):355–363. doi: 10.1042/cs0550355. [DOI] [PubMed] [Google Scholar]
  2. Blitzer B. L., Boyer J. L. Cellular mechanisms of bile formation. Gastroenterology. 1982 Feb;82(2):346–357. [PubMed] [Google Scholar]
  3. Blitzer B. L., Boyer J. L. Localization of Na+,K+-ATPase on the hepatocyte plasma membrane. Gastroenterology. 1984 Nov;87(5):1206–1207. [PubMed] [Google Scholar]
  4. Duffy M. C., Blitzer B. L., Boyer J. L. Direct determination of the driving forces for taurocholate uptake into rat liver plasma membrane vesicles. J Clin Invest. 1983 Oct;72(4):1470–1481. doi: 10.1172/JCI111103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ede R. J., Gove C. D., Hughes R. D., Marshall W., Williams R. Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema. Clin Sci (Lond) 1987 Mar;72(3):365–371. doi: 10.1042/cs0720365. [DOI] [PubMed] [Google Scholar]
  6. Erlinger S. Does Na+-K+-atpase have any role in bile secretion? Am J Physiol. 1982 Oct;243(4):G243–G247. doi: 10.1152/ajpgi.1982.243.4.G243. [DOI] [PubMed] [Google Scholar]
  7. Inoue M., Kinne R., Tran T., Arias I. M. Taurocholate transport by rat liver sinusoidal membrane vesicles: evidence of sodium cotransport. Hepatology. 1982 Sep-Oct;2(5):572–579. doi: 10.1002/hep.1840020510. [DOI] [PubMed] [Google Scholar]
  8. Klaassen C. D., Watkins J. B., 3rd Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev. 1984 Mar;36(1):1–67. [PubMed] [Google Scholar]
  9. Leffert H. L., Schenk D. B., Hubert J. J., Skelly H., Schumacher M., Ariyasu R., Ellisman M., Koch K. S., Keller G. A. Hepatic (Na+,K+)-ATPase: a current view of its structure, function and localization in rat liver as revealed by studies with monoclonal antibodies. Hepatology. 1985 May-Jun;5(3):501–507. doi: 10.1002/hep.1840050327. [DOI] [PubMed] [Google Scholar]
  10. Marbet U. A., Shefer S., Leevy C. M. Studies of the influence of immunological and serological factors from patients with cholestasis due to alcoholic or viral hepatitis on biliary function in the rat. Eur J Clin Invest. 1984 Oct;14(5):346–353. doi: 10.1111/j.1365-2362.1984.tb01194.x. [DOI] [PubMed] [Google Scholar]
  11. Ruifrok P. G., Meijer D. K. Sodium ion-coupled uptake of taurocholate by rat-liver plasma membrane vesicles. Liver. 1982 Mar;2(1):28–34. doi: 10.1111/j.1600-0676.1982.tb00175.x. [DOI] [PubMed] [Google Scholar]
  12. Schenk D. B., Leffert H. L. Monoclonal antibodies to rat Na+,K+-ATPase block enzymatic activity. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5281–5285. doi: 10.1073/pnas.80.17.5281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Seda H. W., Hughes R. D., Gove C. D., Williams R. Inhibition of rat brain Na+,K+-ATPase activity by serum from patients with fulminant hepatic failure. Hepatology. 1984 Jan-Feb;4(1):74–79. doi: 10.1002/hep.1840040113. [DOI] [PubMed] [Google Scholar]
  14. Utili R., Abernathy C. O., Zimmerman H. J. Cholestatic effects of Escherichia coli endotoxin endotoxin on the isolated perfused rat liver. Gastroenterology. 1976 Feb;70(2):248–253. [PubMed] [Google Scholar]
  15. Van Dyke R. W., Stephens J. E., Scharschmidt B. F. Effects of ion substitution on bile acid-dependent and -independent bile formation by rat liver. J Clin Invest. 1982 Sep;70(3):505–517. doi: 10.1172/JCI110642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vergani D., Mieli-Vergani G., Alberti A., Neuberger J., Eddleston A. L., Davis M., Williams R. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med. 1980 Jul 10;303(2):66–71. doi: 10.1056/NEJM198007103030202. [DOI] [PubMed] [Google Scholar]
  17. Wilkinson S. P., Arroyo V., Gazzard B. G., Moodie H., Williams R. Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet. 1974 Mar 30;1(7857):521–524. doi: 10.1016/s0140-6736(74)92711-1. [DOI] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES